- Home
- HRTX vs BCIC Comparison
HRTX vs BCIC Comparison
Compare HRTX & BCIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | HRTX | BCIC |
|---|---|---|
| Founded | 1983 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 146.8M | 162.3M |
| IPO Year | 2007 | N/A |
Fundamental Metrics
Financial Performance| Metric | HRTX | BCIC |
|---|---|---|
| Price | $0.79 | $7.33 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 2 | 2 |
| Target Price | $4.50 | ★ $9.00 |
| AVG Volume (30 Days) | ★ 2.2M | 147.5K |
| Earning Date | 05-05-2026 | 03-05-2026 |
| Dividend Yield | N/A | ★ 14.65% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $154,904,000.00 | N/A |
| Revenue This Year | $15.28 | $5.07 |
| Revenue Next Year | $20.29 | N/A |
| P/E Ratio | ★ N/A | $7.27 |
| Revenue Growth | ★ 7.36 | N/A |
| 52 Week Low | $0.75 | $7.11 |
| 52 Week High | $2.61 | $13.50 |
Technical Indicators
Market Signals| Indicator | HRTX | BCIC |
|---|---|---|
| Relative Strength Index (RSI) | 30.25 | 20.64 |
| Support Level | N/A | N/A |
| Resistance Level | $1.41 | $12.33 |
| Average True Range (ATR) | 0.06 | 0.35 |
| MACD | -0.00 | -0.04 |
| Stochastic Oscillator | 13.10 | 8.99 |
Price Performance
Historical ComparisonAbout HRTX Heron Therapeutics Inc.
Heron Therapeutics Inc is a commercial-stage biotechnology company. The company is focused on improving the lives of patients by developing treatments and commercializing therapeutic solutions to address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.
About BCIC BCP Investment Corporation
BCP Investment Corp is a closed-end, externally managed, non-diversified management investment company. The company invests in performing, well- established middle market businesses that operate across a wide range of industries. It employs fundamental credit analysis, targeting investments in businesses with relatively low levels of cyclicality and operating risk.